Magnesium Glycinate and Ubiquinol: Dosing and Contraindications
For magnesium supplementation in general health contexts, start with 250-500 mg elemental magnesium daily from magnesium glycinate, and for ubiquinol, use 100-300 mg daily; avoid magnesium in severe renal impairment (creatinine clearance <20 mL/min) and use ubiquinol cautiously with anticoagulants.
Magnesium Glycinate Dosing
The optimal dose depends on your clinical indication:
General supplementation and constipation management:
- Start with 250-500 mg elemental magnesium daily 1, 2
- For chronic constipation specifically, magnesium oxide (a different formulation) has been studied at 1.5 g/day, though doses of 0.5-1 g/day are commonly used in practice 3, 1
- Magnesium glycinate may offer better tolerability than magnesium oxide, with fewer gastrointestinal side effects 4, 5
For refractory hypomagnesemia or malabsorption:
- Higher doses may be needed, as magnesium glycinate uses alternative absorption pathways that can bypass malabsorption issues 4
- Titrate based on serum magnesium levels and clinical response
Important dosing considerations:
- Increase dose gradually to minimize gastrointestinal upset 3
- Divided doses throughout the day improve tolerance
- Take with food if gastrointestinal symptoms occur 6
Ubiquinol Dosing
Standard supplementation:
- 100-300 mg daily is the typical range 7, 8, 9
- For athletic performance enhancement: 300 mg daily 7
- For advanced heart failure: 450-900 mg daily may be needed 8
Absorption characteristics:
- Ubiquinol demonstrates dose-dependent, non-linear absorption 9
- Peak plasma levels occur within hours of administration
- No safety concerns identified at doses up to 300 mg for extended periods 9
Contraindications and Precautions
Magnesium Glycinate
Absolute contraindications:
- Severe renal impairment (creatinine clearance <20 mL/min) - risk of hypermagnesemia 3
- End-stage renal disease without dialysis
Relative contraindications and cautions:
- Moderate renal impairment: reduce dose and monitor serum magnesium levels 6
- Concurrent use with fluoroquinolone antibiotics: separate dosing by several hours to avoid decreased antibiotic efficacy 10
- Patients on chronic diuretics may have increased magnesium requirements due to urinary losses 6
Drug interactions:
- Fluoroquinolones: Magnesium binds to quinolones, reducing antibiotic absorption - separate administration by at least 2-4 hours 10
- Bisphosphonates: similar chelation concerns
- Aminoglycosides and other nephrotoxic agents: monitor more closely 6
Ubiquinol
No absolute contraindications identified in the evidence, but consider:
Precautions:
- Anticoagulant therapy (warfarin): Coenzyme Q10 has structural similarity to vitamin K and may theoretically affect INR, though this is not well-established 11
- Monitor INR more frequently if initiating ubiquinol in patients on warfarin
- No specific renal or hepatic dose adjustments documented 9
Drug interactions:
- Potential interaction with warfarin (theoretical, based on vitamin K-like structure)
- Statin medications: ubiquinol may help mitigate statin-related muscle symptoms, but this is not a contraindication
Clinical Pearls
For magnesium:
- Refractory hypokalemia may indicate underlying hypomagnesemia - check magnesium levels in patients with persistent low potassium despite supplementation 6
- Gastrointestinal side effects (diarrhea, cramping) are dose-dependent and the primary limiting factor 3, 1
- Magnesium glycinate appears better tolerated than magnesium oxide with fewer GI side effects 4, 5
For ubiquinol:
- Well-tolerated with minimal adverse events across studied doses 7, 8, 9
- May be particularly beneficial in heart failure patients with documented CoQ10 deficiency 8
- Athletes may see modest performance benefits at 300 mg daily 7
Common pitfall: Do not exceed recommended magnesium doses (generally <1.5 g elemental magnesium daily) to avoid hypermagnesemia, particularly in those with any degree of renal impairment 3, 1.